Comparative efficacy of PD-1 inhibitors plus lenvatinib and regorafenib after lenvatinib failure for advanced hepatocellular carcinoma: a real-world study
Source: Hepatology International - Category: Infectious Diseases Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Infectious Diseases | Liver Cancer | Study